HUMA — Humacyte Cashflow Statement
0.000.00%
Last trade - 00:00- $475.14m
- $413.55m
Annual cashflow statement for Humacyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -85.4 | -66.5 | -26.5 | -12 | -111 |
| Depreciation | |||||
| Non-Cash Items | 4.59 | 4.97 | -62.4 | -68.4 | 23.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.3 | -2.37 | -0.557 | 1.03 | 6.57 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -71.8 | -55.6 | -81.2 | -71.1 | -73.3 |
| Capital Expenditures | -8.13 | -0.318 | -0.22 | -1.05 | -2.28 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.05 | -8 | 5.89 | 2.11 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -8.13 | -0.268 | -8.22 | 4.84 | -0.173 |
| Financing Cash Flow Items | 0 | 0 | -3.94 | 0 | 38 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.074 | 2.05 | 267 | -1.45 | 4.51 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -80 | -53.8 | 178 | -67.7 | -69 |